Endocrine Abstracts

Previous issue | Volume 84 | ETA2022 | Next issue

44th Annual Meeting of the European Thyroid Association (ETA) 2022

Brussels, Belgium
10 Sept 2022 - 13 Sept 2022

Oral Presentations

Oral Session 9: Thyroid Cancer Clinical

Previous section
Oral Session 8: Basic 2

Table of contents

Next section
Oral Session 10: Young Investigators / Clinical and Translational

ea0084op-09-42 | Oral Session 9: Thyroid Cancer Clinical

Childhood papillary thyroid carcinoma: long-term postoperative outcome and prediction of recurrent disease in 189 patients consecutively treated at the mayo clinic during 1936 through 2020

ea0084op-09-43 | Oral Session 9: Thyroid Cancer Clinical

Novel somatic mutations in sporadic MTC (spMTC); clinical utility of NGS in precision medicine

ea0084op-09-44 | Oral Session 9: Thyroid Cancer Clinical

Dynamic risk stratification in long-term clinical outcome of papillary thyroid cancer patients

ea0084op-09-45 | Oral Session 9: Thyroid Cancer Clinical

The phenotype correlated with RET V804 germline mutation is characterized by the presence of medullary thyroid cancer alone

ea0084op-09-46 | Oral Session 9: Thyroid Cancer Clinical

Interim outcome analysis of prospective ATA recurrence risk (RR) stratification for postoperative treatment and follow up of differentiated thyroid cancer (DTC)

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more